Apeloa Pharmaceutical Co., Ltd.

Operates across four lines: active ingredients, CDMO services, finished dosage forms and aesthetic and care ingredients. It reports seven API plants and two finished-product plants in Zhejiang, Shandong and Anhui, covering cardiovascular, anti-infective, psychotropic and oncology areas. Its platforms include flow chemistry, synthetic biology and peptide synthesis. Founded in 1989.